Vimarsana
Biggest News Aggregation in the World

David Buckeridge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Buckeridge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Buckeridge Today - Breaking & Trending Today

Data on COVID-19 in Canadians' blood show impact of vaccination campaigns, new study finds - Vimarsana News

Data on COVID-19 in Canadians' blood show impact of vaccination campaigns, new study finds

With the EG.5 version of the virus now a variant of interest, the findings carry lessons for the next phase of the COVID-19 response

COVID-19: 75 per cent of Canadians were infected by virus by spring 2023 - Vimarsana News

COVID-19: 75 per cent of Canadians were infected by virus by spring 2023

A surge in infections from the Omicron variant last respiratory virus season left three quarters of Canada's population with immunity against the virus that causes COVID-19.

Most people in Canada now have hybrid immunity against COVID-19 - Vimarsana News

Most people in Canada now have hybrid immunity against COVID-19

Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.

COVID keeps evolving, but so does our immunity. Are we now at a 'stalemate' with this virus? - Vimarsana News

COVID keeps evolving, but so does our immunity. Are we now at a 'stalemate' with this virus?

After billions of global COVID-19 infections, millions of deaths, and countless lives upended by long-lasting health impacts, we’ve finally hit a point in this pandemic where SARS-CoV-2 isn’t the fearsome pathogen it used to be. That's thanks to how both the virus, and our immunity against it, are evolving.

Source: cbc.ca
Canada's path to hybrid immunity during pandemic charted in new study - Vimarsana News

Canada's path to hybrid immunity during pandemic charted in new study

With the EG.5 version of the virus now a variant of interest, the findings carry lessons for the next phase of the COVID-19 response